patient
undergo
solid
organ
transplant
sot
may
acquir
infect
transplant
organ
routin
screen
common
infect
establish
part
pretranspl
evalu
donor
recipi
likewis
strategi
exist
prophylaxi
surveil
common
donorassoci
infect
includ
hepat
b
cmv
ebv
howev
despit
advanc
diagnost
test
evalu
infecti
risk
donor
unanticip
transmiss
pathogen
occur
particularli
donor
asymptomat
subtl
unusu
manifest
transmiss
infect
infecti
diseas
id
provid
play
integr
role
donor
recipi
risk
assess
advis
transplant
center
organ
util
guid
evalu
manag
sot
recipi
consider
donor
caus
death
preced
clinic
syndrom
import
character
potenti
risk
recipi
infect
allow
accur
analysi
risk
benefit
accept
lifesav
organ
risk
infect
id
provid
transplant
team
work
close
organ
procur
organ
opo
solicit
addit
donor
inform
donorderiv
infect
suspect
report
facilit
ensur
commun
careteam
organ
recipi
donor
nation
advisori
committe
work
close
feder
agenc
provid
oversight
guid
polici
develop
assess
outcom
assist
prevent
manag
donortransmit
diseas
organ
transplant
clinic
vignett
review
highlight
complex
evalu
potenti
donor
transmiss
organ
transplant
recipi
acquir
latent
activ
infect
transplant
organ
system
circul
donor
potenti
donortorecipi
transmiss
pathogen
cytomegaloviru
cmv
latent
white
blood
cell
hepat
b
viru
hbv
liver
parenchyma
anticip
routin
screen
donor
organ
harvest
howev
unexpect
transmiss
infect
includ
mycobacterium
tuberculosi
infect
histoplasmosi
west
nile
viru
rabi
strongyloid
sp
infect
other
donor
recipi
report
mani
case
unanticip
infecti
transmiss
donor
asymptomat
subtl
symptom
render
difficult
identifi
possibl
infecti
concern
routin
screen
donor
might
detect
recent
acquir
infect
infecti
diseas
id
provid
play
integr
role
pretranspl
risk
assess
provid
recommend
screen
guidanc
posttranspl
risk
reduct
patient
list
solid
organ
transplant
sot
pretranspl
id
evalu
becom
routin
compon
transplant
clinic
care
provid
opportun
provid
educ
patient
famili
prophylaxi
latent
infect
ensur
optim
pretranspl
immun
recipi
perform
test
base
recipientspecif
exposur
exampl
screen
strongyloid
spp
recommend
transplant
candid
area
endem
includ
limit
live
southeastern
unit
state
addit
identifi
address
infecti
risk
among
sot
recipi
id
provid
offer
critic
expertis
peritranspl
period
help
mitig
potenti
risk
donorderiv
infect
id
physician
also
advis
transplant
surgeon
regard
risk
accept
organ
given
clinic
symptom
known
infect
donor
candid
assist
local
organprocur
organ
opo
case
review
recommend
addit
test
donor
nation
organ
procur
transplant
network
optn
within
us
depart
health
human
servic
task
oversight
polici
develop
outcom
assess
sot
across
geograph
transplant
region
unit
state
diseas
transmiss
advisori
group
began
review
potenti
donortransmit
case
ad
hoc
diseas
transmiss
advisori
committe
dtac
offici
establish
part
optn
patient
safeti
program
role
dtac
examin
unexpect
potenti
donorderiv
transmiss
event
primarili
involv
infect
malign
dtac
review
case
determin
whether
donor
deriv
work
center
diseas
control
prevent
cdc
assess
select
case
public
health
interest
addit
dtac
evalu
aggreg
data
transmiss
event
enhanc
patient
safeti
inform
polici
chang
improv
exist
screen
notif
process
dtac
serv
resourc
ongo
educ
within
transplant
commun
although
case
review
dtac
ongo
decad
public
guidanc
document
advis
provid
regard
donor
assess
screen
strategi
littl
known
potenti
donorderiv
transmiss
event
pediatr
adult
donor
pediatr
recipi
systemat
review
unanticip
pediatricspecif
potenti
transmiss
event
report
dtac
conduct
donor
recipi
age
year
studi
period
investig
identifi
deceas
pediatr
donor
account
organ
transplant
given
adult
pediatr
recipi
pediatr
donor
unexpect
potenti
donorderiv
transmiss
event
report
dtac
studi
period
identifi
proven
probabl
event
infect
account
event
result
infect
transmiss
recipi
organ
donor
import
note
transmiss
diseas
donor
recipi
result
death
attribut
infect
studi
highlight
key
differ
risk
pediatr
adult
donor
pediatr
donor
much
like
transmit
viral
infect
adult
donor
report
anoth
larg
dtac
adult
cohort
infect
gener
far
primari
transmiss
event
type
pediatr
donor
recipi
optn
polici
establish
infecti
risk
assess
potenti
donor
medic
travel
social
histori
donor
includ
data
medic
care
patient
donor
hospit
consid
import
recogn
limit
histori
often
provid
donor
famili
member
might
awar
medic
inform
risk
factor
particularli
older
children
teenag
cdc
expand
criteria
identif
disclosur
inform
regard
donor
increas
risk
human
immunodefici
viru
hiv
hbv
hepat
c
viru
hcv
infect
reduc
risk
transmit
infect
organ
transplant
optn
mandat
test
potenti
donor
tabl
hcv
nucleic
acid
test
nat
mandat
donor
detect
acut
infect
set
neg
serolog
result
donor
consid
us
public
health
servic
ph
increas
risk
donor
ird
also
must
undergo
hiv
nat
hiv
nat
perform
routin
donor
servic
area
greater
preval
hiv
exist
includ
area
new
york
lo
angel
tabl
addit
donorspecif
test
screeningprophylaxi
base
travel
area
endem
eg
trypanosoma
cruzi
chaga
diseas
strongyloid
spp
endem
fungi
coccidiomycosi
tuberculosi
malaria
might
recommend
id
provid
often
ask
provid
guidanc
regard
accept
organ
recipi
manag
set
known
suspect
donor
infect
consider
given
transmiss
consequ
particular
infect
transplant
recipi
immunosuppress
also
balanc
risk
declin
scarc
organ
might
lifesav
recipi
guidanc
given
id
provid
inform
structur
depend
individu
institut
region
polici
decis
regard
specif
donor
circumst
often
must
made
casebycas
basi
one
exampl
structur
systemsbas
process
identifi
case
warrant
id
provid
review
infecti
diseas
work
group
idwg
establish
medic
advisori
board
new
york
organ
donor
network
liveonni
idwg
includ
transplant
id
physician
provid
telephon
consult
potenti
donor
infecti
concern
identifi
initi
experi
group
led
develop
list
redflag
condit
acut
dissemin
encephalomyel
alert
liveonni
coordin
request
idwg
consult
idwg
consult
provid
advic
regard
infecti
transmiss
risk
need
addit
test
recommend
prophylaxi
recipi
idwg
also
provid
recommend
regard
emerg
infect
need
screen
west
nile
zika
viru
although
formal
program
id
evalu
assess
case
exist
institut
region
experi
highlight
valu
ensur
routin
commun
collabor
transplant
center
transplant
id
team
follow
case
illustr
typic
scenario
id
provid
must
evalu
assist
recommend
organ
procur
set
possibl
donor
infect
organ
procur
team
call
advic
regard
infecti
risk
procur
offer
organ
infant
present
commun
hospit
histori
fever
max
seizur
prodrom
histori
rhinorrhea
cough
respiratori
distress
vomit
diarrhea
rash
report
sibl
live
home
day
runni
nose
cough
one
els
famili
sick
recent
travel
outsid
unit
state
report
infant
deterior
rapidli
appear
uncontrol
seizur
activ
comput
tomographi
brain
reveal
multipl
area
infarct
pertin
laboratori
result
includ
respiratori
viru
multiplex
polymeras
chain
reaction
pcr
panel
posit
influenza
coronaviru
neg
blood
urin
cultur
result
cerebrospin
fluid
csf
obtain
laboratori
result
includ
prothrombin
time
second
partial
thromboplastin
time
second
alanin
aminotransferas
concentr
ul
aspart
aminotransferas
concentr
ul
albumin
concentr
gdl
patient
treat
hour
empir
vancomycin
cefotaxim
acyclovir
mgkg
bodi
weight
per
dose
everi
hour
id
differenti
diagnosi
infant
includ
influenzaassoci
enceph
herp
simplex
viru
hsv
virus
bacteri
diseas
perspect
evalu
potenti
infecti
risk
donor
bacteri
etiolog
less
concern
blood
cultur
result
neg
patient
receiv
hour
antibiot
therapi
furthermor
sever
studi
document
safeti
transplant
organ
donor
treat
bacteremia
includ
bacteri
mening
acut
influenzaassoci
enceph
syndrom
lead
diagnosi
given
result
respiratori
viru
panel
sibl
home
possibl
influenza
infect
influenzaassoci
enceph
uncommon
well
describ
associ
poor
outcom
exampl
australian
childhood
enceph
studi
databas
patient
influenzaassoci
enceph
identifi
death
signific
morbid
occur
howev
result
respiratori
viru
multiplex
pcr
panel
also
could
repres
colon
resolv
infect
caus
enceph
hsv
clearli
potenti
caus
infant
ill
consist
elev
liver
transaminas
level
low
albumin
level
coagulopathi
initi
recommend
opo
perform
pcr
assay
hsv
serum
possibl
obtain
csf
hsv
influenza
pcr
test
infant
donor
new
york
opo
also
recommend
new
york
state
enceph
panel
test
although
result
panel
would
avail
transplant
new
york
state
enceph
panel
includ
realtim
pcr
adenoviru
cmv
epsteinbarr
viru
enterovirus
hsv
type
human
herpesviru
type
varicellazost
viru
test
arbovirus
eastern
equin
west
nile
viru
includ
also
avail
summer
recommend
antibiot
acyclovir
continu
oseltamivir
ad
result
blood
hsv
pcr
neg
csf
obtain
infant
heart
donat
recipi
underw
oseltamivir
prophylaxi
infecti
complic
report
riskbenefit
ratio
organ
consid
individu
influenza
respiratori
viru
infect
includ
coronaviru
potenti
caus
signific
morbid
sot
recipi
particularli
lung
lesser
extent
intestin
recipi
current
guidelin
recommend
potenti
lung
intestin
donor
diagnos
influenza
within
previou
week
disqualifi
donat
howev
recommend
might
tailor
donor
receiv
day
antivir
therapi
organ
heart
liver
kidney
accept
absenc
complet
antivir
treatment
cours
addit
consent
obtain
donor
recipi
undergo
antiinfluenza
treatment
prophylaxi
respect
oseltamivirresist
influenza
gener
preclud
donat
although
suscept
test
typic
perform
readili
avail
current
guidelin
also
suggest
allograft
patient
suspect
viral
enceph
accept
risk
transmiss
west
nile
viru
lymphocyt
choriomening
viru
hsv
howev
recommend
must
made
consid
risk
potenti
benefit
absenc
viremia
hsv
like
transmit
via
heart
transplant
viru
present
liver
kidney
author
experi
transplant
heart
donor
hsv
enceph
treat
acyclovir
neg
serum
pcr
result
perform
success
young
man
found
pulseless
bathroom
needl
besid
emerg
medic
servic
administ
naloxon
result
respons
start
chest
compress
intub
patient
despit
intens
care
fix
dilat
pupil
declar
brain
dead
day
admiss
medic
social
histori
obtain
patient
wife
reveal
use
heroin
year
famili
agre
organ
donat
blood
test
result
hiv
hcv
hbv
neg
accord
nat
serolog
analysi
call
liver
transplant
team
assist
assess
risk
donor
transmiss
despit
neg
test
result
deceas
donor
consid
ph
ird
riski
behavior
hemodilut
screen
specimen
law
potenti
recipi
must
counsel
consent
use
ph
ird
organ
time
list
patient
provid
consent
ird
organ
offer
grow
opioid
epidem
continu
increas
number
previous
healthi
young
peopl
becom
donor
risk
factor
note
therefor
import
understand
test
procedur
window
eclips
period
help
assess
true
risk
transmiss
chanc
nat
result
fals
neg
scenario
influenc
window
period
viru
sensit
screen
test
risk
donor
acquir
one
virus
recent
past
risk
miss
infect
window
period
depend
assay
use
hiv
would
miss
intraven
drug
donor
use
serolog
compar
use
nat
hcv
decreas
dramat
miss
hcv
case
serolog
compar
nat
recent
articl
cdc
perform
mathemat
model
unit
state
found
overal
risk
low
decreas
even
longer
donor
test
time
last
potenti
exposur
risk
nat
result
inaccur
estim
hcv
risk
almost
zero
test
perform
least
day
exposur
recipi
risk
miss
transmiss
infect
must
counter
risk
take
organ
remain
wait
list
child
fulmin
hepat
failur
intens
care
unit
risk
die
next
day
might
substanti
greater
minim
risk
donor
window
period
contrast
stabl
child
home
might
abl
wait
anoth
organ
offer
rather
accept
possibl
risk
unidentifi
infect
counsel
reflect
balanc
import
also
consid
potenti
treat
recipi
transmiss
hcv
hbv
hiv
occur
exampl
current
studi
examin
deliber
use
hcvposit
donor
seroneg
adult
recipi
part
ph
guidelin
optnunit
network
organ
share
polici
institut
protocol
place
assess
potenti
transmiss
transplant
predetermin
interv
patient
receiv
ph
ird
organ
essenti
note
howev
despit
test
risk
consider
ird
organ
studi
renal
transplant
recipi
found
good
graft
outcom
overal
minim
id
transmiss
infect
remain
signific
caus
morbid
death
among
transplant
recipi
advanc
screen
practic
donor
test
strategi
develop
broader
consensu
guidelin
evalu
manag
infecti
risk
instrument
reduc
donorderiv
infect
associ
complic
among
recipi
although
mani
potenti
donor
infect
identifi
risk
assess
screen
pretranspl
peritranspl
period
infect
might
recogn
immedi
posttranspl
period
result
becom
avail
id
provid
call
evalu
recipi
set
offer
recommend
regard
manag
recipi
exposur
infect
commun
opo
regard
exposur
infect
identifi
posttranspl
period
remain
critic
alert
recipi
organ
donor
emerg
previous
unknown
infect
caus
zika
viru
might
transmiss
donor
recipi
also
area
id
provid
contribut
valuabl
expertis
improv
test
method
molecular
test
gene
sequenc
enabl
identif
infect
might
detect
previous
clinic
implic
might
unclear
multidrugresist
organ
donor
might
necessit
complic
manag
strategi
use
recipi
id
provid
continu
import
role
provid
guidanc
regard
issu
help
ensur
optim
outcom
